del Monte Publications

Articles, Review and Book Chapters


O r i g i n a l   A r t i c l e s


  1. Greco C, Di Piero V, Cavalletti C, Argentino C, D'Agostino R, del Monte F, Scopinaro F. Myocardial ischemia during stroke: scintigraphic demonstration. Cardiologia 1989; 34 (5): 455-457.
  2. Alessandri N, Pannarale G, del Monte F, Moretti F, Marino B, Reale A. Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature. Eur Heart J 1990; 11 (n): 1041-1048.
  3. Jones SM, Hunt NA, del Monte F, Harding SE. Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP. Eur J Pharmacol 1990; 191 (2):129-140.
  4. Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Poole-Wilson PA. Isolated ventricular myocytes from failing ad non failing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 1992; 24 (5): 549-564.
  5. Harding SE, Jones SM, Vescovo G, del Monte F, Poole-Wilson PA. Reduced contractile response to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol 1992; 223 (1): 39-48.
  6. Monti F, Dawodu AA, Giglio V, Lanti M, del Monte F, Sugimoto S, Terracciano C, Schiariti M, Puddu PE, Campa PP. Effetti inotropi e batmotropi della beta stimolazione: studio di confronto tra dobutamina e dopamina nel muscolo papillare di cavia in contrazione isometrica. Cardiologia 1992; 37 (19): 635-639.
  7. del Monte F, Mynett JR, Sugden PH, Poole-Wilson PA, Harding SE. Subcellular mechanism of the species difference in the contractile response of ventricular myocytes to endothelin-1. Cardioscience 1993; 4 (3): 185-191.
  8. del Monte F, Kaumann AJ, Poole-Wilson PA, Wynne DG, Harding SE. Coexistence of functioning b1- and b2-adrenoceptors in single myocytes from failing human ventricle. Circulation 1993; 88 (3): 854-863.
  9. Naqvi RU, del Monte F, O'Gara P, Harding SE, MacLeod KT. Characteristics of myocytes isolated from the heart of renovascular hypertensive guinea-pigs. Am J Physiol 1994; 266 (5 Pt 2): H1886-H1895.
  10. Ferrara N, O'Gara P, Wynne DG, Brown LA, del Monte F, Poole-Wilson PA, Harding SE. Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging guinea-pigs. J Mol Cell Cardiol 1995; 27(5): 1141-1150.
  11. Sanders L, Lynham JA, Bond B, del Monte F, Harding SE, Kaumann AJ. Sensitisation of human atrial 5-HT4 receptors by chronic b-blocker treatment. Circulation 1995; 92 (9): 2526-2539.
  12.  del Monte F, O'Gara P, Poole-Wilson PA, Yacoub M, Harding SE. Cell geometry and contractile abnormalities of myocytes from failing human ventricle. Cardiovasc Res 1995; 30 (2): 281-290.
  13. Sugimoto S, Puddu PE, Monti F, Dawodu AA, del Monte F, Schiariti M, Campa PP, Marino B. Activation of ATP-dependent K+ channels enhances myocardial protection due to cold high potassium cardioplegia: a force-frequency relationship study. J Mol Cell Cardiol 1995; 27 (9): 1867-1881.
  14. Lefroy DC, Crake T, del Monte F, Vescovo G, Dalla Libera LD, Harding SE, Poole-Wilson PA. Angiotensin II and contraction of isolated myocytes from human, guinea-pig and infarcted rat hearts. Am J Physiol 1996; 270 (Pt 2): H2060-H2069.
  15. Harding SE, Brown LA, del Monte F, Davies CH, O'Gara P, Vescovo G, Wynne DG, Poole-Wilson PA. Acceleration of contraction by b-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol 1996; 91 Suppl 2: 53-56.
  16. Wynne DG, del Monte F, Harding SE. Cyclic AMP levels in ventricular myocytes from noradrenaline-treated guinea-pigs. Eur J Pharmacol 1996; 310: 235-242.
  17. Harding S.E., Brown L.A., del Monte F, Davies C.H., O'Gara P., Vescovo G., Wynne D.G., Poole-Wilson P.A. Acceleration of contraction by b-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol 1996; 91 Suppl 2: 53-56.
  18. del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A, Hajjar RJ. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999; 100: 2308-2311.
  19. Matsui T, del Monte F, Li L, Fukui Y, Franke TF, Hajjar RJ, Rosenzweig A. Adenoviral gene transfer of activated PI3-kinase and Akt inhibits apoptosis of hypoxic cardiocytes. Circulation 1999; 100: 2373-2379.
  20. Choukroun G, Hajjar R, Fry S, del Monte F, Haq S, Guerrero JL, Picard M, Rosenzweig A, Force T. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinase/c-Jun NH2-terminal kinases. J Clin Invest 1999; 104 (4): 391-398.
  21. Picard S, Criniti A, Iwashiro K, Rouet R, Monti F, Tonelli E, Ruvolo G, Ducourt P, del Monte F, Papalia U, Puddu PE. Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim. J Cardiovasc Pharmacol 1999; 34 (1): 162-172.
  22. Schmidt U, del Monte F, Miyamoto MI, Matsui T, Gwathmey JK, Rosenzweig A, Hajjar RJ. Restoration of diastolic function in senescent rat hearts by adenoviral gene transfer of sarcoplasmic reticulum Ca2+ ATPase. Circulation 2000; 101 (7): 790-796.
  23. Myamoto MI, del Monte F, Schmidt U, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci 2000; 97 (2): 793-798.
  24. Miyamoto MI, Semigran MJ, del Monte F, Guerrero JL, Gwathmey JK, Bloch KD, Hajjar RJ. Decreased left ventricular mechanical efficiency I NOS3-deficient mice. Proc Natl Acad Sci 2000; 97 (2): 793-798.
  25. Haq S, Choukroun G, Lim HW, Tymitz KM, del Monte F, Gwathmey JK, Grazette L, Michael A, Hajjar RJ, Force TL, Molkentin J. Differential activation of signal transduction pathways in human hearts during hypertrophy and failure. Circulation 2001; 103: 670 - 677.
  26. DeWindt LJD, Lim HW, Bueno OF, Tymititz KM, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, Molkentin JD. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci 2001; 98: 3322-3327.
  27. Davia K, Bernobich E, Ranu HK, del Monte F, Terracciano CM, MacLeod KT, Adamson DL, Chaudhri B, Hajjar RJ, Harding SE. SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. J Mol Cell Cardiol 2001; 33(5):1005-1015.
  28. Matsui T, Tao J, Lee K-H, Li L, del Monte F, Picard M, Franke TF, Hajjar RJ, Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia. Circulation 2001; 104: 330-335.
  29. del Monte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK, Lewandowski D, Hajjar RJ. Improvement in survival and cardiac metabolism following gene transfer of SERCA2a in an animal model of heart failure. Circulation 2001; 104:1424-1429.
  30. del Monte F, Harding S, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban in human heart failure by gene transfer. Circulation 2002; 105: 904-907.
  31. del Monte F, Butler K, Boecker W, Gwathmey JK, Lewandowski D, Hajjar RJ. Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Physiol Genom 2002; 9: 49-56.
  32. Carr A, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Gerst M, Allen PB, Greengard P, Yatani, A, Hoit B, Grupp I, Hajjar RJ, dePaoli-Roach A, Kranias E. Type 1 phosphatase A negative regulator of cardiac function. Mol Cell Biol 2002 22: 4124-4135.
  33. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe P, Hajjar RJ, Linke M. Titin isoform switch in ischemic human heart disease. Circulation 2002; 106: 1333-1341.
  34. Chaudhri B, del Monte F, Hajjar RJ, Harding SE. Interaction between increased SERCA2a activity and b-adrenoceptor stimulation in adult rabbit myocytes. Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2450-7.
  35. Nakayama A*, del Monte F*, Hajjar RJ, Frangioni JV. Functional imaging for surgery and targeted gene therapy. Mol Imaging; 2002: 1: 365-377.
  36. Chaudhri B, del Monte F, Hajjar JR, Harding SE. Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes. Mol Cell Biochem; 2003; 251:103-109.
  37. del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK, Hajjar RJ. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. PNAS 2004; 101 (15): 5622-5627.
  38. del Monte F, Dalal R, Tabchy A, Couget J, Bloch KD, Peterson R, Hajjar RJ. Transcriptional changes following restoration of SERCA2a levels in failing rat hearts FASEB J Express article July 9, 2004.
  39. Boecker W, Bernecker OY, Wu JC, Zhu X, Sawa T, Grazette L, Rosenzweig A, del Monte F, Schmidt U, Hajjar RJ. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging. 2004 Apr;3(2):69-75.
  40. Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke. WA.Passive Stiffness Changes Due To Upregulation of Compliant Titin Isoforms in Human Dilated Cardiomyopathy Hearts. Circ Res. 2004 Oct 1;95(7):708-16.
  41. Lebeche D, Kaprielian R, del Monte F, Tomaselli G, Gwathmey JK, Schwartz A, Hajjar RJ. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 2004 Nov 30;110(22):3435-43.
  42. del Monte F, Kizana E, Tabchy A, Hajjar RJ.Targeted gene transfer in heart failure: implications for novel gene identification. Curr Opin Mol Ther. 2004 Aug;6(4):381-94.
  43. Lebeche D, Kaprielian R, del Monte F, Tomaselli G, Gwathmey JK, Schwartz A, Hajjar RJ. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 2004 Nov 30;110(22):3435-43. Epub 2004 Nov 22.
  44. Harding SE, del Monte F, Hajjar RJ. Antisense strategies for treatment of heart failure. Methods Mol Med. 2005;106:69-82.
  45. Hayase M, del Monte F, MacNeill B, Mcgregor J, Yoneyama R, Kawase Y, Hoshino K, Tsuji T, Hajjar R Catheter-Based Antegrade Intracoronary Viral Gene Delivery with Coronary Venous Blockade Am J Physiol Heart Circ Physiol 2005; 288 (6): H2995-3000.
  46. Pathak A, del Monte F, Zhao W, Schultz JE, Lorenz JN, Bondi I, Weiser D, Hahn H, Carr AN, Syed F, MAvila N, Jha L, Qiuan J, Marreez Y, Chen G, McGraw DW, Heist HK, Guerrero JL, DePaoli-Roach AA, Hajjar RJ, Kranias EG. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res 2005; 96 (7): 756-66.
  47. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings B, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 2005, 115 (8): 2128-2138.
  48. Lipskaia L, del Monte F, Copiod T, Yacoubi S, Hadri L, Hours M, Hajjar RJ, Lompre’ A-M. Sarco/endoplasmic reticulum Ca2+-ATpase gene transfer reduces VSMC proliferation and neointima formation in the rat. Circularion Research 2005, 97 (5): 488-95.
  49. Tsuji T, Hayase M, Guerrero JL, Abe T, Yoshikawa Y, Kobayashi S, Taniguchi S, Takaki M, Hajjar RJ, del Monte F. Efficient Cardiac Gene Transfer Using Percutaneous Aortic Occlusion Technique in the Rat. (submitted)
  50. Dally S, Bredoux R, Corvazier E, Andersen JP, Clausen JD, Dode L, Fanchaouy M, Gelebart P, Monceau V, del Monte F, Gwathmey JK, Hajjar R, Chaabane C, Bobe R, Raies A, Enouf J. Ca 2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca 2+ATPase 2 isoform (SERCA2c). Biochem J. 2006 Apr 15;395(2):249-58.
  51. Sakata S, Lebeche D, Sakata Y, Sakata N, Chemaly ER, Liang LF, Padmanabhan P, Konishi N, Takaki M, del Monte F, Hajjar RJ. Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther. 2006 May;13(5):987-96.
  52. Prunier F, Pfister O, Hadri L, Liang L, del Monte F, Liao R, Hajjar RJ. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H522-9.
  53. Gregory KN, Ginsburg KS, Bodi I, Hahn H, Marreez YM, Song Q, Padmanabhan PA, Mitton BA, Waggoner JR, del Monte F, Park WJ, Dorn GW 2nd, Bers DM, Kranias EG. Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function.J Mol Cell Cardiol. 2006 May;40(5):653-65.
  54. Sakata S, Lebeche D, Sakata Y, Sakata N, Chemaly E, Liang L, Nakajima-Takenaka C, Tsuji T, Konishi N, del Monte F, Hajjar RJ, Takaki M. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type II diabetic rat model. Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1204-7.
  55. Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Tsuji T, Takewa Y, del Monte F, Peluso R, Zsebo K, Jeong D, Park WJ, Kawase Y, Hajjar RJ. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol. 2007 Jan 10.
  56. Palomeque J, Chemaly ER, Colosi P, Wellman JA, Zhou S, del Monte F, Hajjar RJ. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
    Gene Ther. 2007 Jan 25.
  57. Arvanitis DA, Vafiadaki E, Fan GC, Mitton BA, Gregory KN, del Monte F, Kontrogianni-Konstantopoulos A, Sanoudou D, Kranias EG. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1581-9.
  58. Beeri R, Yosefy C, Guerrero JL, Nesta F, Abedat S, Chaput M, del Monte F, Handschumacher MD, Stroud R, Sullivan S, Pugatsch T, Gilon D, Vlahakes GJ, Spinale FG, Hajjar RJ, Levine RA. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol. 2008 Jan 29;51(4):476-86.
  59. del Monte F, Macgillivray TE, Semigran MJ, Dec GW, Hajjar RJ, Doye AA, Glass R, El M, Gwathmey JK. Fingerprint profile of alcohol-associated heart failure in human hearts. Alcohol Clin Exp Res. 2008 May;32(5):814-21.P.
  60. Neilan TG, Ton-Nu TT, Kawase Y, Yoneyama R, Hoshino K, del Monte F, Hajjar RJ, Picard MH, Levine RA, Hung J. Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes. Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2106-11.
  61. Haddad GE, Saunders LJ, Crosby SD, Carles M, del Monte F, King K, Bristow MR, Spinale FG, Macgillivray TE, Semigran MJ, Dec GW, Williams SA, Hajjar RJ, Gwathmey JK. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol Genomics. 2008 Apr 22;33(2):267-77.
  62. Prunier F, Kawase Y, Gianni D, Scapin C, Danik SB, Ellinor PT, Hajjar RJ, del Monte F: Prevention of ventricular arrhythmias with SERCA2a overexpression in a porcine model of ischemia reperfusion. Circulation 2008; Aug 5;118(6):614-24.

R e v i e w s


  1. Puddu PE, del Monte F, Reale A. Cronorischio e morte improvvisa: orizzonte nuovo per la ricerca. Cardiologia 1989; 34 (3): 191-194.
  2. del Monte F, Harding SE, Puddu PE, Poole-Wilson PA. Isolated cardiac myocytes: preparation and use in experimental cardiology. Cardiologia 1991; 36 (4): 319-329.
  3. Harding SE, del Monte F, Poole-Wilson PA. Relaxation abnormalities in myocytes isolated from human ventricle. Proceedings IUPS, Glasgow, Scotland, 1993.
  4. Harding SE, Davia K, Davies CH, del Monte F, Money-Kyrle AR, Poole-Wilson PA. From overload to failure: What happens inside the myocyte. Ann Med 1998; 30 (suppl1): 14-23.
  5. Force TL, Hajjar RJ, del Monte F, Ro senzweig A, Choukroun G. Signaling pathways mediating the response to hypertrophic stress in the heart. Gene Express 1999; 7: 337-348.
  6. Hajjar RJ, del Monte F, Matsui T, Rosenzweig A. Prospects for gene therapy for heart failure. Circ Res 2000; 86: 616-621.
  7. del Monte F, Hajjar RJ, Harding SE, Inesi G. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure . Circ Res 2001; 88: e66-e67.
  8. Kaprielian R, del Monte F, Hajjar RJ. Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer. Basic Res Cardiol (suppl.) 2002; 97:136-145.
  9. Huq F, del Monte F, Hajjar RJ. Modulating signaling pathways in hypertrophy and heart failure by gene transfer. J Cardiac Fail 2002; 8 (6): S389-S400.
  10. Harding SE, del Monte F. Dissociation of hypertrophic growth from changes in myocyte contractile function. J Cardiac Fail 2002: 8 (6): S415-S420.
  11. del Monte F, Johnson CM, Stephanek BA, Doye BA, Gwathmey JK. Defects in calcium control. J Cardiac Fail 2002: 8 (6): S421-S431.
  12. del Monte F, Hajjar RJ. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol (London) 2003; 546: 49-61.
  13. del Monte F, Hajjar RJ. Efficient viral gene transfer to rodent hearts in vivo. Methods Mol Biol 2003;219:179-93.
  14. Bernecker O, del Monte F, Hajjar RJ. Gene therapy for the treatment of heart failure – calcium signaling. Semin Thoracic Cardiovasc Surg 2003;15 (3):268-76.
  15. Chaudri BB, del Monte F, Harding SE, Hajjar RJ. Gene transfer in cardiac myocytes. Surg Clin North Am. 2004: 84 (1) 141-59.
  16. Harding SE, del Monte F, Hajjar RJ. Antisense strategies for treatment of heart failure. Methods Mol Med. 2004;106:69-82.
  17. Bukhari F, Macgillivray T, del Monte F, Hajjar RJ. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications. Expert Rev Cardiovasc Ther. 2005 Jan;3(1):85-97.
  18. Gianni D, Chan J, Gwathmey JK, del Monte F, Hajjar RJ. SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr. 2005 Dec;37(6):375-80.
  19. del Monte F, Hajjar RJ. Devastating heart failure. Heart Failure Review, 2008, March 18.

B o o k   C h a p t e r s


  1. Piccolo GP, Macchiarelli AG, Scibilia G, del Monte F. Protocolli relativi a particolari precauzioni da seguire nel trattamento del ricevente, nel periodo post-operatorio immediato. In: Marino B, Piccoli G, editors. Il Trapianto Cardiaco Ortotopico. Roma: Masson; 1990. p. 191-193.
  2. Piccolo GP, Macchiarelli AG, Scibilia G, del Monte F. Protocolli di comportamento e di condotta del personale addetto alla cura del ricevente nel periodo post-operatorio immediato. In: Marino B, Piccoli G, editors. Il Trapianto Cardiaco Ortotopico. Roma: Masson; 1990. p. 195-198.
  3. Jones SM, Hunt NA, del Monte F, Harding SE. Reduced contractile response to stimulation by isoprenaline, forskolin and dibutyryl cAMP in isolated myocytes from noradrenaline-treated rats. In: Anonymous, editors. Adrenoceptors: Structure, Mechanisms, Function. Advances in Pharmacological Science. The Pharmacology of Adrenoceptors. E Szabadi: Basel; 1991. p. 331-332.
  4. Harding SE, Brown LA, del Monte F, O'Gara P, Wynne DG, Poole-Wilson PA. Parallel changes in the b-adrenoceptor/adenylyl cyclase system between the failing human heart and the noradrenaline-treated guinea-pig. In: Nagano M, Takeda N, Dhalla NS, editors. The Cardiomyopathic Heart. Raven Press; 1993. p. 361-374.
  5. Davies CH, Brown LA, del Monte F, Poole-Wilson PA, Harding SE. Myocardial cell abnormalities in heart failure: experience from studies on single myocytes. In: Dhalla NS, editors. Heart Hypertrophy and Failure. Boston-Dordrecht-London: Kluwer Academic Publishers; 1994. Chapter 16.
  6. del Monte F, Puddu P.E., Harding S.E. b-adrenoceptor desensitisation in human heart failure: focus on isolated myocytes. In: Puddu PE, Bing RJ, Campa PP, Poole-Wilson PA, editors. Congestive Heart Failure: From Basic Science to Therapeutics. Roma: Cardioricerca; 1997. p. 39-62.
  7. del Monte F, Harding SE, Hajjar RJ. Manipulation of SERCA2a in the heart by gene transfer. In: Hasensfuss G, Marban E. Molecular Strategy to the Therapy of Heart Failure. Springer; 2000. p. 53-68.
  8. Gwathmey JK, del Monte F, Kaprielian R, Hajjar RJ. Abnormalities of calcium homeostasis and defective excitation-contraction coupling in cardiomyopathy. In: Willerson JT, editor. Pathogenic Basis of Myocardial Diseases. Kluwer Publishers; 2002. Chapter 8. p133-152.
  9. del Monte F, Hajjar RJ. Efficient viral gene transfer to rodent hearts in vivo. In: Metzger J, editor. Methods in Molecular Biology: Cardiac Cell & Gene Transfer. Vol. 219. Totowa, NJ: Humana Press; 2002. Chapter 14.
  10. Harding SE, del Monte F, Hajjar RJ. Antisense strategies for the treatment of heart failure. In: Phillips I, editor. Antisense Therapeutics, 2nd Edition. 2002.
  11. Gorza L, del Monte F. Protein unfolding in cardiomyopathies. Heart Failure Clinic, Elsevier Saunders. Editors; Hajjar RJ, del Monte F (Guest), Narula J, Young JB (consulting) p 237-250.
  12. Lebeche D, Dalal R, Jang M, del Monte F, Hajjar RJ. Transgenic models of Heart failure: Elucidation of the Molecular Mechanisms of Heart Disease. Heart Failure Clinic, Elsevier Saunders. Editors; Hajjar RJ, del Monte F (Guest), Narula J, Young JB (consulting) p 219-236.
  13. Hajjar RJ, del Monte F Guest Editors: Heart Failure Clinic, Elsevier Saunders. Editors; Narula J, Young JB (Consulting Editor.
  14. Coggins M, Rosenzweig A, del Monte F. Excitation-Contraction Coupling Mechanismsin Heart Failure, Heart Failure, Second Edition, Semigran MJ, Shin JT Editors, Informa Healthcare USA, Inc.

Search